Nephros (NEPH)

• Market cap: $45.2M
• 1 day: 1.19%
• 5 days: 11.23%
• 1 month: 0%
• 3 months: 6.23%
• 6 months: 156.63%
• Year to date: 191.78%
• 1 year: 127.81%
• 5 years: -42.35%
• 10 years: -34.76%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Employees: 31

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

147% more capital invested

Capital invested by funds: $8.02M [Q1] → $19.8M (+$11.8M) [Q2]

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

11% more funds holding

Funds holding: 18 [Q1] → 20 (+2) [Q2]

1.77% more ownership

Funds ownership: 44.01% [Q1] → 45.77% (+1.77%) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $6
• Avg. target: $6
• High target: $6

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Maxim Group Anthony Vendetti

$6

Buy Maintained

8 Aug 2025